Navigation Links
Blood pressure drugs don't protect against colorectal cancer
Date:5/13/2012

A new study has found that, contrary to current thinking, taking beta blockers that treat high blood pressure does not decrease a person's risk of developing colorectal cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study also revealed that even long-term use or subtypes of beta blockers showed no reduction of colorectal cancer risk.

In recent years, researchers have thought that beta blockers, which are prescribed to many older adults for high blood pressure and heart conditions, might be linked with a decreased risk of cancer. This theory stems from animal and laboratory studies that found that the stress hormone norepinephrine can promote the growth and spread of cancer cells. Beta blockers inhibit norepinephrine's action, so it stands to reason that the medications could have anticancer properties.

Previous studies on beta blockers' effects on colorectal cancer risk have yielded inconsistent results. To provide more thorough information, Michael Hoffmeister, PhD, of the German Cancer Research Center, in Heidelberg, Germany, and his colleagues conducted personal interviews from 2003 to 2007 with 1,762 patients with colorectal cancer and 1,708 cancer-free individuals.

After taking into consideration certain patient characteristics (such as weight and smoking status) and other factors that might influence the results, the researchers found no link between beta blocker use and colorectal cancer risk. Previous studies had not taken these factors into consideration. Even when the investigators broke down their analyses by duration of use of beta blockers, specific types of beta blockers, active ingredients (metoprolol, bisoprolol, carvedilol, and atenolol), and sites within the colon or rectum where colorectal cancer developed, there was no link.

Overall, the results of this study do not support the hypothesis that using beta blockers can lower one's colorectal cance
'/>"/>

Contact: Amy Molnar
healthnews@wiley.com
Wiley-Blackwell
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Blood Clot Risk Linked to Some Non-Pill Contraceptives
2. T-Shirt, Gift Card Giveaways Raise Blood Drives Success
3. Cancer Cells in Bloodstream Show Great Diversity: Study
4. Procedure gives patients with A-fib who cant take blood thinners alternative to reduce stroke
5. Liver fat gets a wake-up call that maintains blood sugar levels
6. Study identifies possible protective blood factors against Type 2 diabetes
7. Researchers Rejuvenate Blood-Forming Stem Cells in Mice
8. Whos the Dad? First-Trimester Blood Test May Tell
9. Blood pressure drugs linked with lower PTSD symptoms
10. Researchers determine vitamin D blood level for reducing major medical risks in older adults
11. Can Blood Test Predict Breast Cancer Risk?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... (PRWEB) April 01, 2015 BioPlus ... innovative specialty pharmacies, has released a new app to ... guidelines for treating chronic hepatitis C virus (HCV) infection. ... based on information from the American Association for the ... sources. , Numerous new direct-acting oral medications to treat ...
(Date:4/1/2015)... Northfield, IL, Bethesda, MD, Alexandria, VA (PRWEB) April ... for Clinical Pathology (ASCP), the College of American ... and the American Society of Clinical Oncology (ASCO) ... guideline on the use of molecular marker testing ... This evidence-based guideline will help establish standard molecular ...
(Date:4/1/2015)... 2015 EAGAN, Minn. (April 1, 2015) ... family of companies (Blue Cross) today announced audited financial ... with net income of $61.5 million, reflecting positive investment ... reported a net operating loss of $8.2 million on ... margin of one-tenth of one percent (0.1%). , ...
(Date:4/1/2015)... SCI Solutions , the health industry’s ... that CEO Joel French will be a featured speaker ... in Chicago, April 12-16, 2015. French will co-present ... Coordination Strategies ” with Northeast Georgia Health System (NGHS) ... than 38,000 healthcare industry professionals are expected at the ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 Dr. ... informational seminars in April to discuss the benefits of ... for those suffering from periodontal disease. People who live ... suffer from gum disease can now visit Dr. Stewart, ... traditional gum surgery. With the LANAP® protocol, which is ...
Breaking Medicine News(10 mins):Health News:BioPlus Specialty Pharmacy Releases ‘HCV Treatment Path’ App for Hepatitis C Providers 2Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 2Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 3Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 4Health News:Blue Cross and Blue Shield of Minnesota Reports 2014 Results 2Health News:Blue Cross and Blue Shield of Minnesota Reports 2014 Results 3Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 2Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 3Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 4Health News:Dr. Daniel C. Stewart Offers Columbia Area Residents an Informational Seminar in April About Less Invasive Gum Disease Treatment Now Available at Smile Savers Dentistry 2Health News:Dr. Daniel C. Stewart Offers Columbia Area Residents an Informational Seminar in April About Less Invasive Gum Disease Treatment Now Available at Smile Savers Dentistry 3
... Alzheimers disease (AD) has lately been suggested to be ... An increasing volume of evidence indicates that AD is ... important markers in tests of given pathophysiological hypotheses. ... Szeged, Hungary, hypothesized that the onset of AD affects ...
... retirement age has revealed that workers who retire early have ... until they reach 65. //This finding disapproves the existing misconception ... and happier lives as a consequence. ,Men were ... women, as were those on lower incomes compared to those ...
... with the outcome of botulinum-a toxin (BTX-A) detrusor ... overactivity. BTX-A detrusor injections have been described in ... spinal cord injury. ,Researchers from Germany ... successfully in children with a neurogenic bladder. After ...
... by Synovate India and sponsored by Colgate-Palmolive (India) Ltd says ... latest toothpaste available in the market, //the level of oral ... surveyed admitted that they have never been to a dentist ... oral hygiene practices are resulting in a myriad of dental ...
... Health Organization survey reveals that currently more than 5.13 ... more and more number of cases being reported each ... hospitals across the country. ,The priority of ... from falling prey to the disease. Inorder to increase ...
... have found that daily gargling with povidione-iodine reduced the chances ... been published in the American Journal of Preventive Medicine. ... the age group of 18 to 65. , ,The ... gargled water with povidone-iodine, the second group gargled with water ...
Cached Medicine News:Health News:Age-Dependent Alterations Not Specific For Alzheimers Disease 2Health News:A New Approach In Treatment Neurogenic Detrusor Overactivity In Children 2Health News:Condom Vending Machines To Be Installed Across Indian States 2Health News:Daily Gargling May Prevent Common Colds 2
(Date:4/1/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/hz78md/metabolic_testing ) ... Testing Market by Product (CPET, Body Composition Analysis, ... Diseases), by Technology (REE, Body Composition Analysis), by ... to 2019 " report to their offering. ... expected to reach $475.75 million by 2019 from ...
(Date:4/1/2015)... , April 1, 2015 Eli Lilly and Company ... the first quarter of 2015 on Thursday, April 23, 2015.  ... with the investment community and media to further detail the ... at 9:00 a.m. EDT. Investors, media, and the general public ... a link that will be posted on Lilly,s website at ...
(Date:4/1/2015)... YORK , April 1, 2015  The fairness ... or the "Company") by Teva Pharmaceutical Industries ("Teva") is ... shareholder rights law firm.  The investigation focuses on possible ... by the Board of Directors of ASPX for agreeing ... 2015, the Company announced a definitive agreement for Teva ...
Breaking Medicine Technology:Global Metabolic Testing (CPET, Body Composition Analysis, ECG, Portable System) Market 2015-2019 - REE, Body Composition Analysis for Gyms, Sports & Hospital 2Lilly Confirms Date and Conference Call for First-Quarter 2015 Financial Results Announcement 2WeissLaw LLP: Auspex Pharmaceuticals Inc. Acquisition By Teva Pharmaceutical Industries May Not Be In The Best Interest of ASPX Shareholders 2
... (Otix) (Nasdaq: OTIX ), a leading provider of ... decided to discontinue its operations in Germany as of September ... CEO of Otix stated, "the regulatory obstacles in Germany have ... as a result, we have made the decision to discontinue ...
... announced this week that it has received the Japanese ... collection and transfer of biological samples. The Japanese flocked ... growing number of patents held by COPAN across the ... and transfer of biological samples, including the Australian patent ...
Cached Medicine Technology:Otix Global, Inc. to Discontinue German Operations 2Otix Global, Inc. to Discontinue German Operations 3COPAN Secures Japanese Patent for its Flocked Swab Innovation 2
... The NexGen Legacy LCCK Femoral ... require additional prosthetic stabilization due to ... function, and require augmentation and/or stem ... The NexGen LCCK is available with ...
... manufacturers focus attention on implant design, one ... Profix Total Knee System seeks to establish ... system and the tools to implant them. ... recognized for innovation in total knee instrumentation, ...
Cruciate retaining, posterior stabilized and constrained components....
Maximum contact. Minimum wear. Outstanding results....
Medicine Products: